I'm looking for

The Society of Gynecologic Oncology (SGO) COVID-19 resources are produced by the COVID-19 Task Force and dispatched in a rapidly evolving environment with enormous variation depending on time and location. They are not to be construed as hard and fast practice guidelines, but temporary considerations during the COVID-19 emergency crisis.

Given the challenges presented by the COVID-19 pandemic, the following resources and considerations are provided to enable practitioners to deliver cancer care while protecting the health and safety of both patients and members. Data are limited, and these considerations will need to be modified as more information emerges about COVID-19 or further resource stratification becomes necessary as the crisis evolves. The considerations provided may not be applicable in all clinical settings or may need to be modified as different loco-regional situations arise.

 

Keeping Members Informed in the Crisis

SGO Immediate Past President Warner K. Huh, MD, shares SGO’s plans to keep members informed throughout the COVID-19 pandemic.

Key Points:

  • SGO has created a COVID-19 Task Force.
  • SGO will be issuing frequent COVID-19 Communiqués on COVID-19 impacted issues such as patient surgical selection and timing; chemotherapy administration, selection and scheduling; enrollment of and management of patients in clinical trials; resident and fellow education; patient resources; and your own wellness.
  • SGO encourages members to collaborate among themselves via the members-only COVID-19 listserv, a new private Facebook group or on Twitter using #SGOCOVID19.

 

SGO COVID-19 Task Force

The SGO COVID-19 Task Force was created to gather and share important resources about surgery, infusion, clinical trials, resident and fellow education, patient communications, and your own wellness during the COVID19 crisis. This task force consists of representatives from various SGO committees.

SGO Members

Warner K. Huh, MD, 2019-2020 SGO President
Joshua Kesterson, MD, Task Force Co-Chair, Communications
Bhavana Pothuri, MD, Task Force Co-Chair, Clinical Practice
Amanda Nickles Fader, MD, Task Force Co-Chair, SGO Board Liaison
Jeff Lin, MD, Communications
Susan Zweizig, MD, Education
Joshua Cohen, MD, Education
William Burke, MD, Clinical Practice

Gretchen Glaser, MD, Wellness
Leslie Bradford, MD, Wellness
Sandra Brooks MD, MBA, Diversity & Inclusion Task Force
John Farley, MD, COL(ret), Diversity & Inclusion Task Force
Monique Spillman, MD, Ethics
Annie Ellis, Patient Advocate, Ethics
Karen Lyle, PA-C, Advanced Practice Providers
Evonne M. Kandas, MS, WHCNP/FNP-BC, Advanced Practice Providers

SGO Staff

Ellen Sullivan, MS, MSJ, Coordinator
Pierre Desy, MPH, CAE, SGO Chief Executive Officer
Teri Jordan, CAE, CMP, Education, Advanced Practice Providers
Jessica Oldham, Education, Clinical Practice, Ethics
Lindsey Powell, MNM, Communications, Diversity & Inclusion Task Force
Robyn Kurth, MS, Communications
Traci Schwendner, Education, Clinical Practice, Ethics

SGO-produced COVID-19 Resources

Sep 16, 2020

Telemedicine Coding Examples

Type: Coding Tools
Type: CodingCoronavirusTelemedicine
Jun 2, 2020

Survey Results: Impact of COVID-19 on the Practice of Gynecologic Oncology

Type: Report
Type: CoronavirusGynecologic Oncology Subspeciality
Apr 14, 2020

Promoting Health Equity in the COVID-19 Era

Type: Recommendations
Type: CoronavirusHealth Equity
Apr 3, 2020

Anti-cancer Therapy and Clinical Trial Considerations for Gynecologic Oncology Patients During the COVID-19 Pandemic Crisis

Type: Recommendations
Type: ChemotherapyCoronavirus
Apr 3, 2020

Considerations of Continuing Clinical Trials During the COVID-19 Pandemic

Type: Video
Type: Clinical TrialsCoronavirus
Apr 2, 2020

Staying Well During the COVID-19 Pandemic Crisis

Type: Recommendations
Type: CoronavirusWellness
Apr 24, 2020

Present and Future Impact of COVID-19 on the Practice and Delivery of Gynecologic Oncology Care

Type: Journal Podcast
Type: Coronavirus
Apr 1, 2020

Telemedicine Considerations During the COVID-19 Pandemic

Type: Recommendations
Type: CoronavirusTelemedicine
Mar 31, 2020

Gynecologic Oncology Reassignment During the COVID-19 Pandemic

Type: Recommendations
Type: Coronavirus
Mar 27, 2020

Surgical Considerations for Gynecologic Oncologists During the COVID-19 Pandemic

Type: Recommendations
Type: CoronavirusSurgery
Mar 23, 2020

Gynecologic Oncology Considerations during the COVID-19 Pandemic

Type: Recommendations
Type: Coronavirus

COVID-19 Webinars

SGO COVID-19 Webinars are organized in collaboration with the COVID-19 Task Force and produced in a rapidly evolving environment. Information presented is not to be construed as hard and fast practice guidelines, but temporary considerations during the COVID-19 emergency crisis. Topics covered include health equity; surgical, safety and triage considerations; anti-cancer treatments and clinical trial considerations.

Drug Information and Shortages

Certification and Licensure

Telemedicine and Virtual Conferencing

Advocacy

SGO’s COVID-19 resources are generously supported by an independent medical education grant from AstraZeneca.

SGO also thanks the following sponsors for support of our COVID-19 resources:

Advertisement

Join SGO Today

What you get out of membership changes your patient’s lives. What you give from your membership changes the world. Join your community today.

Become a Member